Home
La Jolla Pharmaceutical

La Jolla Pharmaceutical Market Share Analysis for July 2026

Health > Biotechnology and Pharmaceuticals

Domainlajollapharmaceutical.com

Year Founded1989

Employees51 - 200

Annual Revenue$50M - $75M

La Jolla Pharmaceutical

La Jolla Pharmaceutical (including company regionals)

lajollapharmaceutical.com

See more website traffic and engagement information

La Jolla Pharmaceutical Revenue up to July 2026 is 50M - 75M

revenue generated by La Jolla Pharmaceutical top domains

La Jolla Pharmaceutical top domains revenue over 3 years

Revenue for La Jolla Pharmaceutical top domains

lajollapharmaceutical.com50M - 75M

See more with Sales Intelligence

Total visits to La Jolla Pharmaceutical's top domains

Understand La Jolla Pharmaceutical market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in La Jolla Pharmaceutical's top domains

Analyze La Jolla Pharmaceutical engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on La Jolla Pharmaceutical's top domains

See how La Jolla Pharmaceutical keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

La Jolla Pharmaceutical top competitors by domain

Top similar sites in July 2026, ranked by their affinity

novimmune.comCompany NameNovimmune SAEmployees51 - 200HQSwitzerland, Plan-les-OuatesAnnual revenue$25M - $50MTotal visits--Health > Biotechnology and Pharmaceuticals

Top technologies used by La Jolla Pharmaceutical

These are the website technologies, by industry, used by La Jolla Pharmaceutical top domains

Advertising (2)

PubMatic

Audio Video Media (2)

YouTube

Content Management System (2)

WordPress

Mobile (2)

Meta Viewport

More Technologies

6

See all

News & Signals from La Jolla Pharmaceutical

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsInnoviva, Inc. acquires La Jolla Pharmaceutical Company for $149M.Prior to this development, Innoviva signed a definitive merger agreement to acquire all of the outstanding shares of La Jolla Pharmaceutical Company for an enterprise value of nearly $149m, through its wholly owned subsidiary.

NewsLa Jolla Pharmaceutical Company has issues with possible breaches of fiduciary duty and other violations of law.Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of La Jolla Pharmaceutical Company ("La Jolla" or the "Company") (NASDAQ: LJPC) in connection with the proposed acquisition of the Company by Innoviva, Inc. (NASDAQ: INVA) via tender offer.

NewsInnoviva, Inc acquired La Jolla Pharmaceutical Company for $149M on Jul 18th '22.Second, Innoviva agreed to pay $5.95 per share to acquire La Jolla Pharmaceutical.